Rai N, Tiwari R, Sahu A, Verma E, Rathore S, Patil S
Anticancer Agents Med Chem. 2024; 25(2):124-133.
PMID: 39297455
DOI: 10.2174/0118715206260662240613054521.
Sulaiman M, Alabsi W, Szabo L, Hay M, Polt R, Largent-Milnes T
Int J Mol Sci. 2023; 24(19).
PMID: 37834455
PMC: 10573977.
DOI: 10.3390/ijms241915007.
Dolan J, Machin D, Dedola S, Field R, Webb M, Turnbull W
Front Chem. 2022; 10:958272.
PMID: 36186584
PMC: 9515619.
DOI: 10.3389/fchem.2022.958272.
Apostol C, Bernard K, Tanguturi P, Molnar G, Bartlett M, Szabo L
Front Drug Discov (Lausanne). 2022; 1.
PMID: 35237767
PMC: 8887546.
DOI: 10.3389/fddsv.2021.818003.
Alabsi W, Acosta M, Al-Obeidi F, Hay M, Polt R, Mansour H
Pharmaceutics. 2021; 13(8).
PMID: 34452239
PMC: 8398878.
DOI: 10.3390/pharmaceutics13081278.
The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced Dyskinesia.
Bartlett M, Mabrouk O, Szabo L, Flores A, Parent K, Bidlack J
Int J Mol Sci. 2020; 22(1).
PMID: 33374986
PMC: 7792611.
DOI: 10.3390/ijms22010020.
Glycopeptide drugs: A pharmacological dimension between "Small Molecules" and "Biologics".
Apostol C, Hay M, Polt R
Peptides. 2020; 131:170369.
PMID: 32673700
PMC: 7448947.
DOI: 10.1016/j.peptides.2020.170369.
Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model.
Bartlett M, So L, Szabo L, Skinner D, Parent K, Heien M
BMC Res Notes. 2020; 13(1):149.
PMID: 32164786
PMC: 7066739.
DOI: 10.1186/s13104-020-04994-7.
Simple and Efficient Preparation of O- and S-GlcNAcylated Amino Acids through InBr-Catalyzed Synthesis of β- N-Acetylglycosides from Commercially Available Reagents.
De Leon C, Lang G, Saavedra M, Pratt M
Org Lett. 2018; 20(16):5032-5035.
PMID: 30088936
PMC: 6215763.
DOI: 10.1021/acs.orglett.8b02182.
Functional crosstalk between histone H2B ubiquitylation and H2A modifications and variants.
Wojcik F, Dann G, Beh L, Debelouchina G, Hofmann R, Muir T
Nat Commun. 2018; 9(1):1394.
PMID: 29643390
PMC: 5895630.
DOI: 10.1038/s41467-018-03895-5.
ISWI chromatin remodellers sense nucleosome modifications to determine substrate preference.
Dann G, Liszczak G, Bagert J, Muller M, Nguyen U, Wojcik F
Nature. 2017; 548(7669):607-611.
PMID: 28767641
PMC: 5777669.
DOI: 10.1038/nature23671.
The Sulfur-Linked Analogue of O-GlcNAc (S-GlcNAc) Is an Enzymatically Stable and Reasonable Structural Surrogate for O-GlcNAc at the Peptide and Protein Levels.
De Leon C, Levine P, Craven T, Pratt M
Biochemistry. 2017; 56(27):3507-3517.
PMID: 28627871
PMC: 5598463.
DOI: 10.1021/acs.biochem.7b00268.
The New Chemical Reporter 6-Alkynyl-6-deoxy-GlcNAc Reveals O-GlcNAc Modification of the Apoptotic Caspases That Can Block the Cleavage/Activation of Caspase-8.
Chuh K, Batt A, Zaro B, Darabedian N, Marotta N, Brennan C
J Am Chem Soc. 2017; 139(23):7872-7885.
PMID: 28528544
PMC: 6225779.
DOI: 10.1021/jacs.7b02213.
Design, Synthesis, Molecular Docking Analysis, and Carbonic Anhydrase IX Inhibitory Evaluations of Novel N-Substituted-β-d-Glucosamine Derivatives that Incorporate Benzenesulfonamides.
Li F, Fan Z, Qi S, Wang Y, Wang J, Liu Y
Molecules. 2017; 22(5).
PMID: 28498332
PMC: 6154466.
DOI: 10.3390/molecules22050785.
CNS active O-linked glycopeptides.
Jones E, Polt R
Front Chem. 2015; 3:40.
PMID: 26157795
PMC: 4478441.
DOI: 10.3389/fchem.2015.00040.
The disaccharide moiety of bleomycin facilitates uptake by cancer cells.
Schroeder B, Ghare M, Bhattacharya C, Paul R, Yu Z, Zaleski P
J Am Chem Soc. 2014; 136(39):13641-56.
PMID: 25184545
PMC: 4183664.
DOI: 10.1021/ja507255g.
Development of a bioavailable μ opioid receptor (MOPr) agonist, δ opioid receptor (DOPr) antagonist peptide that evokes antinociception without development of acute tolerance.
Mosberg H, Yeomans L, Anand J, Porter V, Sobczyk-Kojiro K, Traynor J
J Med Chem. 2014; 57(7):3148-53.
PMID: 24641190
PMC: 3993928.
DOI: 10.1021/jm5002088.
Can amphipathic helices influence the CNS antinociceptive activity of glycopeptides related to β-endorphin?.
Li Y, St Louis L, Knapp B, Muthu D, Anglin B, Giuvelis D
J Med Chem. 2014; 57(6):2237-46.
PMID: 24576160
PMC: 3983389.
DOI: 10.1021/jm400879w.
Synthesis of fluorous photolabile aldehyde and carbamate and alkyl carbamate protecting groups for carbohydrate-associated amines.
Roychoudhury R, Pohl N
Org Lett. 2014; 16(4):1156-9.
PMID: 24512452
PMC: 3993871.
DOI: 10.1021/ol500023y.
Translation of structure-activity relationships from cyclic mixed efficacy opioid peptides to linear analogues.
Anand J, Porter-Barrus V, Waldschmidt H, Yeomans L, Pogozheva I, Traynor J
Biopolymers. 2014; 102(1):107-14.
PMID: 24436042
PMC: 4132888.
DOI: 10.1002/bip.22437.